These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3809855)

  • 21. Effectiveness of applying progressive muscle relaxation technique on quality of life of patients with multiple sclerosis.
    Ghafari S; Ahmadi F; Nabavi M; Anoshirvan K; Memarian R; Rafatbakhsh M
    J Clin Nurs; 2009 Aug; 18(15):2171-9. PubMed ID: 19583649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Plasmapheresis: its use in multiple sclerosis and other demyelinating processes of the central nervous system. An observation study].
    Meca-Lallana JE; Rodríguez-Hilario H; Martínez-Vidal S; Saura-Luján I; Carretón-Ballester A; Escribano-Soriano JB; Martín-Fernández J; Genovés-Aleixandre A; Mateo-Bosch E; Fernández-Barreiro A
    Rev Neurol; 2003 Nov 16-30; 37(10):917-26. PubMed ID: 14634919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of myelin basic protein-like material in cerebrospinal fluid of multiple sclerosis patients with their response to glucocorticoid treatment.
    Whitaker JN; Layton BA; Herman PK; Kachelhofer RD; Burgard S; Bartolucci AA
    Ann Neurol; 1993 Jan; 33(1):10-7. PubMed ID: 7684211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural history of multiple sclerosis: a unifying concept.
    Confavreux C; Vukusic S
    Brain; 2006 Mar; 129(Pt 3):606-16. PubMed ID: 16415308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase I study of a humanized anti-CD11/CD18 monoclonal antibody in multiple sclerosis.
    Bowen JD; Petersdorf SH; Richards TL; Maravilla KR; Dale DC; Price TH; St John TP; Yu AS
    Clin Pharmacol Ther; 1998 Sep; 64(3):339-46. PubMed ID: 9757158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of eye movement examination and subjective visual vertical in clinical evaluation of multiple sclerosis.
    Serra A; Derwenskus J; Downey DL; Leigh RJ
    J Neurol; 2003 May; 250(5):569-75. PubMed ID: 12736736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thymectomy in multiple sclerosis. Two preliminary trials.
    Ferguson TB; Clifford DB; Montgomery EB; Bruns KA; McGregor PJ; Trotter JL
    J Thorac Cardiovasc Surg; 1983 Jan; 85(1):88-93. PubMed ID: 6848891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum IgG and IgM ganglioside GM1 antibodies in patients with multiple sclerosis.
    Zaprianova E; Majtényi K; Deleva D; Mikova O; Filchev A; Sultanov B; Kolyovska V; Sultanov E; Christova L; Kmetska X; Georgiev D
    Ideggyogy Sz; 2004 Mar; 57(3-4):94-9. PubMed ID: 15133910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma exchange in chronic progressive multiple sclerosis: a long-term study.
    Khatri BO; McQuillen MP; Hoffmann RG; Harrington GJ; Schmoll D
    Neurology; 1991 Mar; 41(3):409-14. PubMed ID: 2006010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma exchange in the management of patients with multiple sclerosis: preliminary observations.
    Valbonesi M; Garelli S; Mosconi L; Zerbi D; Forlani G
    Vox Sang; 1981; 41(2):68-73. PubMed ID: 7331281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meta-analysis of clinical studies of the efficacy of plasma exchange in the treatment of chronic progressive multiple sclerosis.
    Vamvakas EC; Pineda AA; Weinshenker BG
    J Clin Apher; 1995; 10(4):163-70. PubMed ID: 8770707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperimmune bovine colostrum inefficacious as multiple sclerosis therapy in double-blind study.
    Bayard BL; James MA
    J Am Diet Assoc; 1987 Oct; 87(10):1388-90. PubMed ID: 3309014
    [No Abstract]   [Full Text] [Related]  

  • 33. [Electrotherapeutic modification of sensory-reactive and deficiency manifestations in multiple sclerosis].
    Hufschmidt HJ; Wüst R
    Nervenarzt; 1976 Jan; 47(1):12-8. PubMed ID: 1082557
    [No Abstract]   [Full Text] [Related]  

  • 34. A double-blind controlled pilot study of plasma exchange versus sham apheresis in chronic progressive multiple sclerosis.
    Gordon PA; Carroll DJ; Etches WS; Jeffrey V; Marsh L; Morrice BL; Olmstead D; Warren KG
    Can J Neurol Sci; 1985 Feb; 12(1):39-44. PubMed ID: 3884114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An assessment of plasma exchange in progressive multiple sclerosis.
    Weiner HL
    Neurology; 1985 Mar; 35(3):320-2. PubMed ID: 3883234
    [No Abstract]   [Full Text] [Related]  

  • 36. Plasmapheresis in multiple sclerosis: prospective trial of pheresis and immunosuppression versus immunosuppression alone.
    Tindall RS; Walker JE; Ehle AL; Near L; Rollins J; Becker D
    Neurology; 1982 Jul; 32(7):739-43. PubMed ID: 7201110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma exchange in multiple sclerosis.
    Guarnieri BM; Capparelli R; Fratiglioni L; Inzitari D; Sità D; Amaducci L; Avanzi G; Biani D; Franco C; Lombardo R
    Int J Artif Organs; 1985 Jul; 8(4):215-20. PubMed ID: 3902665
    [No Abstract]   [Full Text] [Related]  

  • 38. The modern management of multiple sclerosis.
    Compston A
    Br J Hosp Med; 1986 Sep; 36(3):200-1, 204-8. PubMed ID: 3768608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Towards individualised multiple sclerosis treatment.
    Holmøy T; Hestvik AL; Vartdal F
    Lancet Neurol; 2006 Feb; 5(2):111-2. PubMed ID: 16426986
    [No Abstract]   [Full Text] [Related]  

  • 40. [Apheresis for demyelinating diseases].
    Matsunaga M; Sato T
    Nihon Rinsho; 1992 Jan; 50 Suppl():345-50. PubMed ID: 1315881
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.